C
Corcept Therapeutics Incorporated CORT
$43.98 $2.686.49% NASDAQ
Recommendation
Prev Close
$43.98
Volume
3,946,512
Avg Vol (90D)
1,447,201
Market Cap
$4.63B
Dividend & Yield
--
52-Week Range
$32.99 - $117.33
P/E (TTM)
50.25
EPS (TTM)
$0.88
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Biopharmaceutical Stocks Bucking the Sell-Off
4/10/2025 - MarketBeat
Corcept Therapeutics (CORT) Valuation Check After Wild Share Price Swings
1/23/2026 - Simply Wall St
Corcept Therapeutics (NASDAQ:CORT) Shares Up 6.8% Following Analyst Upgrade
1/23/2026 - MarketBeat
CORT Rises as Relacorilant Meets OS Endpoint in Ovarian Cancer Study
1/23/2026 - Zacks Investment Research
Traders Purchase Large Volume of Put Options on Corcept Therapeutics (NASDAQ:CORT)
1/23/2026 - MarketBeat
Corcept Therapeutics put volume heavy and directionally bearish
1/23/2026 - TipRanks Financial Blog
Corcept Therapeutics put volume heavy and directionally bearish
1/23/2026 - The Fly
Corcept Therapeutics (CORT, $41.3) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 22, 2026
1/23/2026 - Tickeron - Technical Analysis
Corcept Therapeutics (CORT, $41.3) RSI Indicator left the oversold zone on January 22, 2026
1/23/2026 - Tickeron - Technical Analysis
Corcept Therapeutics (CORT, $41.3) price may drop as it broke higher Bollinger Band on Jan 22, 2026
1/23/2026 - Tickeron - Technical Analysis
Corcept Therapeutics (CORT) Climbs 13.7% on Strong Clinical Trial Results
1/23/2026 - Insider Monkey
Corcept Therapeutics price target raised by $1 at Canaccord, here's why
1/23/2026 - The Fly
10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs
1/23/2026 - Insider Monkey
Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up - Should You Buy?
1/22/2026 - MarketBeat
Corcept Therapeutics price target raised to $105 from $90 at H.C. Wainwright
1/22/2026 - TipRanks Financial Blog
Corcept Therapeutics price target raised by $15 at H.C. Wainwright, here's why
1/22/2026 - The Fly
Why Did Corcept Therapeutics Stock Surge Over 14% Today?
1/22/2026 - Stocktwits News Feed
Corcept Therapeutics (CORT) Sees Significant Stock Surge
1/22/2026 - GuruFocus
Corcept Therapeutics Shares Jump 15% After Phase 3 Trial Success
1/22/2026 - RTT News - Momentum Stocks
Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps
1/22/2026 - Benzinga
Corcept Therapeutics rises 17.7%
1/22/2026 - TipRanks Financial Blog
Corcept Therapeutics rises 17.7%
1/22/2026 - The Fly
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
1/22/2026 - PR Newswire
Corcept Therapeutics (CORT) Surges 25% on Positive Trial Results
1/22/2026 - GuruFocus
Corcept Therapeutics (CORT) Phase 3 Trial Achieves Milestone in Ovarian Cancer Treatment
1/22/2026 - GuruFocus
Income Statement
Total Revenue (TTM)
$741.17M
EBITDA (TTM)
$66.71M
EBIT (TTM)
$65.57M
Net Income (TTM)
$106.11M
Balance Sheet
Total Assets (Q)
$823.61M
Total Debt (Q)
$6.36M
Total Liabilities (Q)
$191.71M
Book Value Per Share (Q)
$6.01
Cash Flow
Cash from Operations (TTM)
$162.85M
Cash from Investing (TTM)
$17.24M
Cash from Financing (TTM)
-$193.71M
Net Change in Cash (TTM)
-$12.15M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.22
7-Day Total Return
18.74%
30-Day Total Return
-48.45%
60-Day Total Return
-38.54%
90-Day Total Return
-38.33%
Year to Date Total Return
15.13%
1-Year Total Return
-26.69%
2-Year Total Return
92.30%
3-Year Total Return
93.15%
5-Year Total Return
53.99%
52-week Low
Dec 31, 2025 - $32.99
52-week High
Mar 31, 2025 - $117.33
Valuation
Market Cap
$4.63B - Mid Cap
Enterprise Value
$4.11B
Price/Sales (TTM)
7.09
Price/Book (Q)
7.32
Dividends and Shares
Shares Outstanding
119.44M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.corcept.com
Phone Number
650 327 3270
Address
101 Redwood Shores Parkway
Redwood City, CA 94065
Country
United States
Year Founded
1998
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed